STAM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.793000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.032200E-01
Normal-vs-Stage2
7.947000E-01
Normal-vs-Stage3
8.011900E-02
Normal-vs-Stage4
5.152000E-01
Stage1-vs-Stage2
9.734200E-01
Stage1-vs-Stage3
2.414800E-01
Stage1-vs-Stage4
3.677200E-01
Stage2-vs-Stage3
1.450760E-01
Stage2-vs-Stage4
2.072800E-01
Stage3-vs-Stage4
7.222200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.283000E-01
Normal-vs-AfricanAmerican
7.305400E-01
Normal-vs-Asian
8.177600E-01
Caucasian-vs-AfricanAmerican
2.360400E-01
Caucasian-vs-Asian
9.913800E-01
AfricanAmerican-vs-Asian
4.961800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.689600E-01
Normal-vs-Female
7.965000E-01
Male-vs-Female
9.217800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.033000E-01
Normal-vs-Age(41-60Yrs)
8.404600E-01
Normal-vs-Age(61-80Yrs)
6.289000E-01
Normal-vs-Age(81-100Yrs)
4.927400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.335400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.621000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.968400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.665750E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.519700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.490600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.746800E-01
Normal-vs-Daily Drinker
2.957200E-01
Normal-vs-Weekly Drinker
7.437600E-01
Normal-vs-Occasional Drinker
6.228600E-01
Normal-vs-Social Drinker
9.704200E-01
Non Drinker-vs-Daily Drinker
5.663800E-01
Non Drinker-vs-Weekly Drinker
6.467000E-01
Non Drinker-vs-Occasional Drinker
1.952370E-02
Non Drinker-vs-Social Drinker
1.703180E-01
Daily Drinker-vs-Weekly Drinker
3.884800E-01
Daily Drinker-vs-Occasional Drinker
7.397000E-03
Daily Drinker-vs-Social Drinker
7.011700E-02
Weekly Drinker-vs-Occasional Drinker
1.758970E-01
Weekly Drinker-vs-Social Drinker
5.225800E-01
Occasional Drinker-vs-Social Drinker
4.134600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.623600E-02
Normal-vs-Grade 2
3.942500E-03
Normal-vs-Grade 3
4.715800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.794400E-01
Grade 1-vs-Grade 3
3.492000E-01
Grade 1-vs-Grade 4
4.623600E-02
Grade 2-vs-Grade 3
9.936000E-01
Grade 2-vs-Grade 4
3.942500E-03
Grade 3-vs-Grade 4
4.715800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.225800E-01
Normal-vs-NonDiabetic
6.808600E-01
Diabetic-vs-NonDiabetic
6.174400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.127630E-01
Normal-vs-NoPancreatitis
7.377400E-01
Pancreatitis-vs-NoPancreatitis
4.359600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.132000E-01
Normal-vs-N1
8.162000E-01
N0-vs-N1
5.736000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.835400E-01
Normal-vs-TP53-NonMutant
8.893000E-01
TP53-Mutant-vs-TP53-NonMutant
5.955000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
